Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Victor P. Ryzhenko
Observed names:
Ryzhenko Victor,
Victor RYZHENKO,
Victor Ryzhenko
Institution:
Zaporizhzhia State Medical and Pharmaceutical University
Observed institutions:
Taurida National V.I. Vernadsky University,
Zaporizhzhia State Medical and Pharmaceutical University,
Bogomolets National Medical University
ORCID:
0000-0003-3466-7148
Observed ORCID:
0000-0003-3466-7148
OpenAlex ID:
A5114149672
Methodological Approaches to Experimental Evaluation of Neuroprotective Action of Potential Drugs
2024
·
Igor Belenichev
, Nina Bukhtiyarova
, et al.
·
International Journal of Molecular Sciences
·
28
PDF
Targeting Mitochondrial Dysfunction in Cerebral Ischemia: Advances in Pharmacological Interventions
2025
·
Igor Belenichev
, Olena Popazova
, et al.
·
Antioxidants
·
26
PDF
Optimization of the Search for Neuroprotectors among Bioflavonoids
2024
·
Igor Belenichev
, Victor Ryzhenko
, et al.
·
Pharmaceuticals
·
17
The effect of intranasal administration of an IL-1b antagonist (RAIL) on the state of the nitroxydergic system of the brain during modeling of acute cerebrovascular accident
2021
·
Bogdan S. Burlaka
, Igor F. Belenichev
, et al.
·
Pharmacia
·
17
PDF
Cardioprotective Activity of Pharmacological Agents Affecting NO Production and Bioavailability in the Early Postnatal Period after Intrauterine Hypoxia in Rats
2023
·
Olena Popazova
, Igor Belenichev
, et al.
·
Biomedicines
·
15
PDF
Molecular and Biochemical Mechanisms of Cardiomyopathy Development Following Prenatal Hypoxia—Focus on the NO System
2025
·
Olena Popazova
, Igor Belenichev
, et al.
·
Antioxidants
·
13
PDF
Beta-Blockers of Different Generations: Features of Influence on the Disturbances of Myocardial Energy Metabolism in Doxorubicin-Induced Chronic Heart Failure in Rats
2024
·
Igor Belenichev
, Olexiy Goncharov
, et al.
·
Biomedicines
·
12
PDF
Possibility of Using NO Modulators for Pharmacocorrection of Endothelial Dysfunction After Prenatal Hypoxia
2025
·
Igor Belenichev
, Olena Popazova
, et al.
·
Pharmaceuticals
·
9
PDF
Analysis of influence of quantum chemical descriptors on NO-scavenger properties among xanthine derivatives
2017
·
Olexii A. Ryzhov
, Victor P. Ryzhenko
, et al.
·
Biological Markers and Guided Therapy
·
9
Characteristics of HIF-1Α and HSP70 MRNA Expression, Level, and Interleukins in Experimental Chronic Generalized Periodontitis
2024
·
Parkhomenko Daria
, Belenichev Igor
, et al.
·
MicroRNA
·
7
Principles of metabolithotropic therapy in pediatric practice. Clinical and pharmacological characteristics of modern metabolithotropic agents (part 1)
2022
·
Igor BELENICHEV
, Nadezhda GORCHAKOVA
, et al.
·
Fìtoterapìâ
·
7
PDF
Study of dependence of xanthine derivatives NO-scavenger properties from energy descriptors
2018
·
Victor P. Ryzhenko
, Olexii A. Ryzhov
, et al.
·
Biological Markers and Guided Therapy
·
6
Evaluation of methods of modeling and formation of experimental allergic encephalomyelitis
2022
·
Oleksandr O. Nefodov
, Igor F. Belenichev
, et al.
·
Research Results in Pharmacology
·
5
PDF
Prospects for nasal delivery of a pharmacologic agent for neuroprotective experimental therapy after prenatal hypoxia
2025
·
Igor Belenichev
, Olena Aliyeva
, et al.
·
Frontiers in Systems Neuroscience
·
4
PDF
Integrative and Biochemical Parameters in Rats in the Simulation of Doxorubicin Chronic Heart Failure and During the Use of Β-adrenergic Blockers
2023
·
Igor BELENİCHEV
, Pavlo BAK
, et al.
·
Ankara Universitesi Eczacilik Fakultesi Dergisi
·
4
PDF
Principles of metabolithotropic therapy in pediatric practice. Clinical and pharmacological characteristics of modern metabolithotropic agents (part 1)
2022
·
Igor BELENICHEV
, Nadezhda GORCHAKOVA
, et al.
·
Fìtoterapìâ
·
4
PDF
The Influence of Basic Therapy and New Drugs on NO-Dependent Mechanisms of Cardiac Destruction in Chronic Heart Failure
2026
·
Igor Belenichev
, Olena Popazova
, et al.
·
Biomedicines
·
3
Discovery and Characterization of Novel Spirotriazoloquinazolines as Potential Neuroprotectors: Synthesis, Computational Screening, and Preliminary In Vivo Evaluation
2026
·
Kostiantyn Shabelnyk
, Lyudmyla Antypenko
, et al.
·
Journal of Neurochemistry
·
2
PDF
Bioisosteric Replacement in the Search for Biologically Active Compounds: Design, Synthesis and Anti-Inflammatory Activity of Novel [1,2,4]triazino[2,3-c]quinazolines
2024
·
Oleksandr Grytsak
, Konstantin Schabelnyk
, et al.
·
Pharmaceuticals
·
2
PDF
Principles of metabolithotropic therapy in pediatric practice. Сlinical and pharmacological characteristics of modern metabolithotropic agents (part 2)
2022
·
Igor BELENICHEV
, Nadezhda GORCHAKOVA
, et al.
·
Fìtoterapìâ
·
2
PDF
Development of software for prediction and virtual screening of antioxidant activity of new synthesized azaheterocyclic compounds
2019
·
Victor P. Ryzhenko
, Igor F. Belenichev
, et al.
·
International Journal of Basic & Clinical Pharmacology
·
2
PDF
A multi-agent GraphRAG framework for pharmacotherapy safety verification in clinical decision support systems
2026
·
Victor Ryzhenko
, Bogdan Burlaka
, et al.
·
Frontiers in Medicine
·
1
PDF
Principles of metabolithotropic therapy in pediatric practice. Clinical and pharmacological characteristics of modern metabolithotropic agents (part 2)
2022
·
Igor BELENICHEV
, Nadezhda GORCHAKOVA
, et al.
·
Fìtoterapìâ
·
1
PDF
Cardioprotective Effects of Coupled SH/NO System Modulators in a Rat Model of Doxorubicin-Induced Heart Failure
2026
·
Victor Ryzhenko
, Igor Belenichev
, et al.
·
Metabolites
Molecular cytokine-dependent mechanisms of periodontitis pathogenesis and the potential for pharmacological IL-1 modulation in disease treatment
2026
·
Igor Belenichev
, Olena Popazova
, et al.
·
Frontiers in Dental Medicine
PDF
Show more works
View as search
Works count:
27
Citation count:
196
H-index:
9
I10-index:
7
Year
Topic
Type